Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by Fishercat1on Dec 05, 2020 12:06pm
224 Views
Post# 32043937

RE:RE:RE:RE:MINDMED TO ACQUIRE BUZZ (PHARMADRUG)

RE:RE:RE:RE:MINDMED TO ACQUIRE BUZZ (PHARMADRUG)
GREENBOY wrote:
Fishercat1 wrote:
GREENBOY wrote:
MrAMG7 wrote: New news surfacing that MindMed will buy small cap company BUZZ to expand their operations in Germany/Netherlands. 
 


this loser is posting this crappola on other boards as well first he must be an amateur and second he probably doesn't know that another loser like him (Terry Booth) is part of the Buzz so called lol team don't listen to this clown
Ah but they have  Ceo Cohen , Resin , Linton , and Forbes on that BOD as well . One player does not make a team . Regardless I asked this buffon to post a link to this umm lets call news on the street lmao . Right . Have a great weedend boys and I hope you knock it out of the park here and make great bank . I,m happy to have a huge stack at 4.5 cents for whats going down and would not be able to have such a large mount here as your sp is much higher and prefer the risk/reward of an emerging play . C. I to like my Green Greenboy and lots of it . Do your D@D this weekend you might like what you see for 4.5 cents . Cost nothing to look . Cheers . 
 


I wish you well but after the disaster Booth left at Aurora I swore not to invest into anything this man touched JMO
Agreed . I have a few rotton apples on my list as well and would not buy stock in said companies a la proverbial ten foot pole  . Your money , your call . Cheers . 

<< Previous
Bullboard Posts
Next >>